Literature DB >> 18829679

Prognostic and aetiological factors in chronic thromboembolic pulmonary hypertension.

R Condliffe1, D G Kiely, J S R Gibbs, P A Corris, A J Peacock, D P Jenkins, K Goldsmith, J G Coghlan, J Pepke-Zaba.   

Abstract

Several prognostic variables have previously been identified in patients with chronic thromboembolic pulmonary hypertension (CTEPH). Specific medical conditions have also been associated with the development and prognosis of CTEPH. Using a national registry, the current authors have assessed the prognostic value of a larger number of variables and have also attempted to validate the clinical importance of previously identified aetiological factors. Baseline information for all 469 CTEPH patients diagnosed in the UK pulmonary hypertension service between January 2001 and June 2006 was collected from hospital records. Although univariate analysis confirmed the prognostic importance of pulmonary resistance, in multivariate analysis gas transfer and exercise capacity predicted pulmonary endarterectomy perioperative mortality. Cardiac index and exercise capacity independently predicted outcome in patients with nonoperable disease. Previous splenectomy was noted in 6.7% of patients, being significantly more common in patients with nonoperable than operable disease (13.7 versus 3.6%). Medical risk factors were not found to predict mortality. In a large national cohort, predictors of outcome in patients with both operable and nonoperable chronic thromboembolic pulmonary hypertension have been identified. These may be useful in planning treatment. The aetiological importance of previously identified medical risk factors has been confirmed, although the current authors were unable to validate their prognostic strength.

Entities:  

Mesh:

Year:  2008        PMID: 18829679     DOI: 10.1183/09031936.00092008

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  39 in total

Review 1.  An update on the evaluation and management of pulmonary hypertension in scleroderma.

Authors:  John G Coghlan; Benjamin Schreiber; Benjamin Schrieber
Journal:  Curr Rheumatol Rep       Date:  2012-02       Impact factor: 4.592

Review 2.  Classification and diagnosis of pulmonary hypertension.

Authors:  Hector R Cajigas; Rana Awdish
Journal:  Heart Fail Rev       Date:  2016-05       Impact factor: 4.214

3.  Diagnostic performance of state-of-the-art imaging techniques for morphological assessment of vascular abnormalities in patients with chronic thromboembolic pulmonary hypertension (CTEPH).

Authors:  Sebastian Ley; Julia Ley-Zaporozhan; Michael B Pitton; Jens Schneider; Gesine M Wirth; Eckhard Mayer; Christoph Düber; Karl-Friedrich Kreitner
Journal:  Eur Radiol       Date:  2011-09-27       Impact factor: 5.315

4.  Prediction of hemodynamic improvement after pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension using non-invasive imaging.

Authors:  Bastiaan E Schölzel; Martijn C Post; Alexander van de Bruaene; Steven Dymarkowski; Wim Wuyts; Bart Meyns; Werner Budts; Marion Delcroix
Journal:  Int J Cardiovasc Imaging       Date:  2014-08-22       Impact factor: 2.357

Review 5.  Pulmonary hypertension in patients with heart failure and preserved ejection fraction: differential diagnosis and management.

Authors:  Nehal Hussain; Athanasios Charalampopoulos; Sheila Ramjug; Robin Condliffe; Charlie A Elliot; Laurence O'Toole; Andrew Swift; David G Kiely
Journal:  Pulm Circ       Date:  2016-03       Impact factor: 3.017

6.  Diagnostic evaluation and management of chronic thromboembolic pulmonary hypertension: a clinical practice guideline.

Authors:  Sanjay Mehta; Doug Helmersen; Steeve Provencher; Naushad Hirani; Fraser D Rubens; Marc De Perrot; Mark Blostein; Kim Boutet; George Chandy; Carole Dennie; John Granton; Paul Hernandez; Andrew M Hirsch; Karen Laframboise; Robert D Levy; Dale Lien; Simon Martel; Gerard Shoemaker; John Swiston; Justin Weinkauf
Journal:  Can Respir J       Date:  2010 Nov-Dec       Impact factor: 2.409

7.  Prospective cardiopulmonary screening program to detect chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism.

Authors:  Frederikus A Klok; Klaas W van Kralingen; Arie P J van Dijk; Fenna H Heyning; Hubert W Vliegen; Menno V Huisman
Journal:  Haematologica       Date:  2010-01-06       Impact factor: 9.941

8.  Chronic Thromboembolic Pulmonary Hypertension: Experience from a Single Center in Mexico.

Authors:  Nadine Al-Naamani; Gaudalupe Espitia H; Hugo Velazquez-Moreno; Benjamin Macuil-Chazaro; Arturo Serrano-Lopez; Ricardo S Vega-Barrientos; Nicholas S Hill; Ioana R Preston
Journal:  Lung       Date:  2016-01-09       Impact factor: 2.584

9.  Exercise capacity affects quality of life in patients with pulmonary hypertension.

Authors:  Michael Halank; Franziska Einsle; Stephanie Lehman; Hinrich Bremer; Ralf Ewert; Heinrike Wilkens; F Joachim Meyer; Ekkehard Grünig; Hans-Jürgen Seyfarth; Martin Kolditz; Gesine Wieder; Gert Höffken; Volker Köllner
Journal:  Lung       Date:  2013-05-17       Impact factor: 2.584

Review 10.  Epidemiology and Pathophysiology of Chronic Thromboembolic Pulmonary Hypertension: Risk Factors and Mechanisms.

Authors:  Sarah Medrek; Zeenat Safdar
Journal:  Methodist Debakey Cardiovasc J       Date:  2016 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.